Finnova Capital logo

Finnova Capital

Asia, Beijing, China, Beijing

Description

Finnova Capital is an investment firm.

Investor Profile

Finnova Capital has made 3 investments, with 2 in the past 12 months and 33% as lead.

Stage Focus

  • Series B (67%)
  • Pre Seed (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Association
  • Non Profit
  • Electronics
  • Semiconductor
  • Biopharma
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Finnova Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Qiandao Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Ligong investment
Asia, Shanghai, China, Putuo
Co-Investments: 1
GF Venture Capital
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
DT Capital Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 1
China Merchants Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Huajin Capital
Asia, Guangdong, China, Zhuhai
Co-Investments: 1
SDIC Venture Capital
Asia, Hebei, China, Xicheng
Co-Investments: 1
Horus Capital
Asia, Shandong, China, Qingdao Shi
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by Finnova Capital?

Nanok Biotechnology

Wuhan, Hubei, China

Nanok is a revolutionary antibacterial medication developer company.

BiopharmaBiotechnologyMedical
Pre SeedNov 22, 2024
Microchip

Shenzhen, Guangdong, China

Microchip specializes in the development of new power semiconductor devices, including lGBT, coolmos, SiC, and intelligent power modules.

ElectronicsManufacturingSemiconductor
Series BAug 26, 2024
MabPlex International

Fremont, California, United States

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

AssociationBiotechnologyManufacturingNon Profit
Series BJun 8, 2020
Amount Raised: $70,708,356